July 2003

Successful Sterilization Using Chlorine Dioxide Gas logo in a gray background | Successful Sterilization Using Chlorine Dioxide Gas
Fill/Finish
Successful Sterilization Using Chlorine Dioxide Gas July 2003Successful Sterilization Using Chlorine Dioxide Gas July 2003
Successful Sterilization Using Chlorine Dioxide Gas
Jul 1, 2003
byBPI Contributor
Staying on Top of Changing Regulations logo in a gray background | Staying on Top of Changing Regulations
Regulatory Affairs
Staying on Top of Changing RegulationsStaying on Top of Changing Regulations
Staying on Top of Changing Regulations
Jul 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature July 2003Products, Services, and Literature July 2003
Products, Services, and Literature
Jul 1, 2003
byBPI Contributor
Part 11 Update logo in a gray background | Part 11 Update
Regulatory Affairs
Part 11 UpdatePart 11 Update
Part 11 Update
Jul 1, 2003
byBPI Contributor
Outsourced Aseptic Fill/Finish and Stability Programs for BioPharmaceuticals logo in a gray background | Outsourced Aseptic Fill/Finish and Stability Programs for BioPharmaceuticals
Fill/Finish
Outsourced Aseptic Fill/Finish and Stability Programs for BioPharmaceuticalsOutsourced Aseptic Fill/Finish and Stability Programs for BioPharmaceuticals
Outsourced Aseptic Fill/Finish and Stability Programs for BioPharmaceuticals
Jul 1, 2003
byBPI Contributor
Looking Across the Pond logo in a gray background | Looking Across the Pond
Business
Looking Across the PondLooking Across the Pond
Looking Across the Pond
Jul 1, 2003
byBPI Contributor
International Relations logo in a gray background | International Relations
Regulatory Affairs
International RelationsInternational Relations
International Relations
Jul 1, 2003
byBPI Contributor
21 CFR 11 Revisited logo in a gray background | 21 CFR 11 Revisited
Information Technology
21 CFR 11 Revisited21 CFR 11 Revisited
21 CFR 11 Revisited
Jul 1, 2003
byBPI Contributor
Assessing Facilities for 21 CFR Part 11 logo in a gray background | Assessing Facilities for 21 CFR Part 11
Facility Design/Engineering
Assessing Facilities for 21 CFR Part 11Assessing Facilities for 21 CFR Part 11
Assessing Facilities for 21 CFR Part 11
Jul 1, 2003
byBPI Contributor
Conferences, Courses and, Events logo in a gray background | Conferences, Courses and, Events
Business
Conferences, Courses and, EventsConferences, Courses and, Events
Conferences, Courses and, Events
Jul 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024